Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for Lateral Epicondylitis
NCT00119704Phase 3Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Sep 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Lateral Epicondylitis (LET) comparing Botulinum toxin A with Placebo (2 arms). Primary endpoint: Visual Analog Scale. Started Sep 2002; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT00119704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00119704.